# Response to Exercise and Nitric Oxide in PAD

Study · id `cardio:ct-nct06657976` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06657976](<https://clinicaltrials.gov/study/NCT06657976>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06657976

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT06657976. Randomized; quadruple masking; primary purpose treatment. Start 2025-01-23 (actual); primary completion 2029-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT06657976, source copy `cardio:ctgov-nct06657976-2026-07-27`, retrieved 2026-10-31)
- Started: 2025-01-23 (actual) (ClinicalTrials.gov record NCT06657976, source copy `cardio:ctgov-nct06657976-2026-07-27`, retrieved 2026-10-31)
- Primary completion: 2029-07-01 (anticipated) (ClinicalTrials.gov record NCT06657976, source copy `cardio:ctgov-nct06657976-2026-07-27`, retrieved 2026-10-31)
- Completion: 2029-10-01 (anticipated) (ClinicalTrials.gov record NCT06657976, source copy `cardio:ctgov-nct06657976-2026-07-27`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT06657976, source copy `cardio:ctgov-nct06657976-2026-07-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06657976-2026-07-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: Response to Exercise and Nitric Oxide in PAD
- Acronym: RESIST
- Condition: Peripheral Artery Disease
- Condition: Exercise
- Condition: Intermittent Claudication
- Condition: Nitric Oxide
- Intervention (Behavioral): Supervised Treadmill Exercise
- Intervention (Behavioral): Attention Control
- Intervention (Combination product): Nitrate-Rich Beetroot Juice + supervised exercise therapy
- Intervention (Combination product): Placebo + supervised exercise therapy
- Lead sponsor: Northwestern University
- Lead sponsor class: OTHER
- Collaborator: National Institute on Aging (NIA)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Northwestern University (`cardio:org-northwestern-university`)
- Registry lists this organization as a collaborator: National Institute on Aging (`cardio:nia`)

## Provenance

Content hash: 3d9676db45bf3f9f3d91774657fedfc18fcb5232ce617200e09e3699c1d06ed3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
